Study outcomes
SECONDARY
The primary outcome of the present study was to compare the proportion of patients with frailty reversion, which was defined by the LFI < 4.5, between BCAA and control groups at week 16. The secondary outcomes included changes in LFI, body composition, laboratory parameters at week 8 and 16, and changes in QoL at week 16. QoL was assesses at baseline and at week 16 by the Thai version of the SF-36 questionnaire. This translated version of the SF-36 has been previously validated [